Inventor · disambiguated record
Soren Ebdrup
Also filed as: EBDRUP SOREN
23 granted patents·20 pending applications·68 citations·filing 2001–2024
93Inventor score
Files withEBDRUP SOREN10HIGH POINT PHARMACEUTICALS LLC10NOVO NORDISK AS8JAPAN TOBACCO INC3ANDERSEN HENRIK SUNE1
Top patents by PatentIndex Score
43 records- 0186US8053431B2Pharmaceutical use of substituted amidesHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted Nov 8, 2011·9 cites·8 claims
- 0285US8053447B211β-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Nov 8, 2011·7 cites·10 claims
- 0385US8048908B211β-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2007·Granted Nov 1, 2011·4 cites·6 claims
- 0484US7943669B2Phenoxy acetic acids as PPAR delta activatorsHIGH POINT PHARMACEUTICALS LLC·Filed 2006·Granted May 17, 2011·7 cites·25 claims
- 0584US7037905B2Pharmaceutical use of boronic acids and esters thereofNOVO NORDISK AS·Filed 2003·Granted May 2, 2006·18 cites·59 claims
- 0682US8426473B2Phenoxy acetic acids as PPAR delta activatorsEBDRUP SOREN·Filed 2012·Granted Apr 23, 2013·5 cites·4 claims
- 0781US8217086B2Phenoxy acetic acids as PPAR delta activatorsEBDRUP SOREN·Filed 2011·Granted Jul 10, 2012·5 cites·4 claims
- 0875US2025084106A1PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND SYNTHETIC INTERMEDIATES THEREOFJAPAN TOBACCO INC·Filed 2024·Application pending·0 cites
- 0974US12195481B2Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereofJAPAN TOBACCO INC·Filed 2023·Granted Jan 14, 2025·0 cites·6 claims
- 1073US8383820B2N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenaseHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Feb 26, 2013·1 cites·46 claims
- 1172US7279470B2Compounds and uses thereof for decreasing activity of hormone-sensitive lipaseNOVO NORDISK AS·Filed 2002·Granted Oct 9, 2007·5 cites·52 claims
- 1271US7968723B2Compounds, their preparation and useHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Jun 28, 2011·1 cites·52 claims
- 1367US8470964B2Peptides derived from NCAM (FGLs)BEREZIN VLADIMIR·Filed 2008·Granted Jun 25, 2013·1 cites·22 claims
- 1467US7067517B2Use of compounds for decreasing activity of hormone-sensitive lipaseNERO NORDISK AS·Filed 2002·Granted Jun 27, 2006·5 cites·23 claims
- 1561US8907096B2N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenaseHIGH POINT PHARMACEUTICALS LLC·Filed 2014·Granted Dec 9, 2014·0 cites·24 claims
- 1657US8809540B2N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenaseHIGH POINT PHARMACEUTICALS LLC·Filed 2013·Granted Aug 19, 2014·0 cites·24 claims
- 1756US11673900B2Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereofJAPAN TOBACCO INC·Filed 2017·Granted Jun 13, 2023·0 cites·16 claims
- 1853US8927549B2Adamantyl benzamide derivativesPOLISETTI DHARMA RAO·Filed 2009·Granted Jan 6, 2015·0 cites·63 claims
- 1951US8383683B2Pharmaceutical use of substituted amidesHIGH POINT PHARMACEUTICALS LLC·Filed 2008·Granted Feb 26, 2013·0 cites·6 claims
- 2049US8334305B2N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenaseEBDRUP SOREN·Filed 2008·Granted Dec 18, 2012·0 cites·2 claims
- 2148US8383668B211-beta-hydroxysteroid dehydrogenase type 1 active compoundsHIGH POINT PHARMACEUTICALS LLC·Filed 2011·Granted Feb 26, 2013·0 cites·3 claims
- 2247US2010137377A1Novel compoundsSOREN EBDRUP·Filed 2008·Application pending·0 cites
- 2347US2011003856A1N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenaseEBDRUP SOREN·Filed 2008·Application pending·0 cites
- 2447US2010056600A111beta-hsd1 active compoundsEBDRUP SOREN·Filed 2008·Application pending·0 cites
- 2547US2011003852A1N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenaseEBDRUP SOREN·Filed 2008·Application pending·0 cites
- 2646US2006160865A1Pyridinyl carbamatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2746US2012004209A111-Beta-Hydroxysteroid Dehydrogenase Type 1 Active CompoundsEBDRUP SOREN·Filed 2011·Application pending·0 cites
- 2846US2006148799A1Substituted p-phenyl carbamatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2946US2006148860A1Substituted p-phenyl carbamatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3045US2009325932A14-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitorsEBDRUP SOREN·Filed 2007·Application pending·0 cites
- 3144US7091023B2Stereoselective esterase from Aspergillus oryzaeNOVOZYMES AS·Filed 2001·Granted Aug 15, 2006·0 cites·18 claims
- 3244US2010168083A1Adamantane derivatives for the treatment of the metabolic syndromeEBDRUP SOREN·Filed 2007·Application pending·0 cites
- 3344US2009124598A1Pharmaceutical use of substituted amidesANDERSEN HENRIK SUNE·Filed 2006·Application pending·0 cites
- 3444US2011312949A1Pharmaceutical use of substituted amidesKILBURN JOHN PAUL·Filed 2011·Application pending·0 cites
- 3543US2006160820A1Substituted piperazine carbamatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3643US2006160819A1Substitued piperazine carbamatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3743US2006160851A1Substituted piperidine carbamatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3842US6743608B2Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acidsNOVO NORDISK PHARMACEUTICALS I·Filed 2002·Granted Jun 1, 2004·0 cites·26 claims
- 3942US2003008361A1Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acidsFiled 2002·Application pending·0 cites
- 4039US2002173647A1Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing themREDDY RESEARCH FOUNDATION·Filed 2002·Application pending·0 cites
- 4138US2002119969A1Novel processFiled 2001·Application pending·0 cites
- 4236US9056814B2Polymorphic form of a calcimimetic compoundEBDRUP SOREN·Filed 2011·Granted Jun 16, 2015·0 cites·14 claims
- 4335US2003004341A1Crystalline R-guanidines, arginine or (L)-arginine (2S)-2-ethoxy-3-{4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl}propanoateFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soren Ebdrup files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →